Synthesis of a 1α-C-methyl analogue of 25-hydroxyvitamin D3: interaction with a mutant vitamin D receptor Arg274Leu

Shinobu Honzawa, Naoyuki Takahashi, Atsushi Yamashita, Takayuki Sugiura, Masaaki Kurihara, Midori A. Arai, Shigeaki Kato, Atsushi Kittaka

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Vitamin D3 analogues have been developed for a mutant vitamin D receptor (VDR), Arg274Leu. The mutant VDR has a mutation at Arg274, which forms an important hydrogen bond with 1α-OH of 1α,25-dihydroxyvitamin D3 to anchor the ligand tightly in the VDR ligand binding pocket. Stereoselective synthesis of the A-ring part of the novel vitamin D analogue, 2α-(3-hydroxypropyl)-1α-methyl-25-hydroxyvitamin D3 (4), from d-galactose was accomplished with the key steps of the introduction of the methyl and allyl groups to the chiral building blocks. The new analogue 4 is ca. 7.3-fold more active than the natural hormone 1α,25-dihydroxyvitamin D3 (1).

Original languageEnglish
Pages (from-to)7135-7145
Number of pages11
Issue number34
Publication statusPublished - 2009 Aug 22
Externally publishedYes


  • Mutant vitamin D receptor
  • Structure-function relationships
  • Vitamin D analogue
  • Vitamin D receptor

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Synthesis of a 1α-C-methyl analogue of 25-hydroxyvitamin D<sub>3</sub>: interaction with a mutant vitamin D receptor Arg274Leu'. Together they form a unique fingerprint.

Cite this